10th International mRNA Health Conference

Cytiva is a global life sciences leader with more than 7,000 associates across 40 countries dedicated to advancing and accelerating therapeutics.

WACKER is a leading player and one of the world’s most research-intensive chemical companies.

PNI is a global leader in ushering in the next wave of genetic medicines in infectious diseases, cancer, and rare diseases.

Quantoom Biosciences, is reinventing mRNA production by developing an RNA Platform that encompasses DNA and RNA manufacturing and formulation, along with critical reagent supply, from sequence to large scale production.

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer.

TriLink’s CDMO services offer a range of manufacturing grade products from discovery-grade (RUO) to its customizable intermediate-grade - GMPLink™ to full GMP-grade with scale-up and technology transfer expertise.

Evonik Health Care is a business line of Evonik Operations GmbH. We partner with the world’s pharmaceutical, medical device and nutraceutical companies to advance human health.

Acuitas is the premier LNP (lipid nanoparticle) technology provider enabling our partners to advance new therapeutics to address unmet clinical needs.

Arcturus Therapeutics a global late-stage messenger RNA medicines and vaccines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases.

Axolabs, a growing company located in Kulmbach (Bavaria, Germany) and Berlin, is a member of the globally active LGC Group.

At BioNTech we understand that every cancer patient’s tumor is unique and therefore each patient’s treatment should be individualized.

Certest Biotec is a biotechnology company dedicated to the development and manufacture of in vitro diagnostic products with human applications.

CureVac is a global biopharmaceutical company in the field of messenger RNA (mRNA) technology, with more than 20 years of expertise in developing and optimizing the versatile biological molecule for medical purposes.

CustomBiotech offers a range of innovative products and services for the biopharma, cell therapy, and in vitro diagnostics markets, customizable to meet your unique quality and regulatory needs.

Eurogentec, part of Kaneka Corporation, is an international biotechnology supplier, based in Belgium, who specializes in genomics and proteomics.

At Moderna, we believe messenger RNA, or mRNA, is the “software of life.” Every cell in the body uses mRNA to provide real-time instructions to make the proteins necessary to drive all aspects of biology, including in human health and disease.

NanoVation Therapeutics (NTx) is an early-stage gene therapy company developing next-generation platform technologies utilizing lipid nanoparticles for the safe and efficient delivery of nucleic acids to a variety of tissues.

ORGANIX, a Massachusetts based corporation established in 1986, conducts research and development under contract in organic chemistry and all related areas.

Polymun is a private company performing contract development and manufacturing of biopharmaceuticals as well as liposomal/LNP formulations. The most recent and prominent examples is Polymun’s contribution to the Covid-19 vaccine of BioNTech/Pfizer.

ReCode Therapeutics is a genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.

“ST Pharm provides reliable and timely custom manufacturing services for API following stringent quality system and close communication with the clients.